• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

PINC

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

    Scindo lands £4m in funding from Kadmos Capital and Clay Capital to develop enzyme platform for sustainable chemicalsScindo lands £4m in funding from Kadmos Capital and Clay Capital to develop enzyme platform for sustainable chemicals
    Scindo
    23 Sept 2025

    Scindo lands £4m in funding from Kadmos Capital and Clay Capital to develop enzyme platform for sustainable chemicals

    Scindo develops an AI-driven enzyme design platform that enables sustainable production of bio-based chemicals and ingredients from renewable feedstocks across multiple industries.

    Elaniti raises £1.3m in venture and Innovate UK funding to advance AI-driven soil intelligence platformElaniti raises £1.3m in venture and Innovate UK funding to advance AI-driven soil intelligence platform
    Elaniti
    19 Mar 2025

    Elaniti raises £1.3m in venture and Innovate UK funding to advance AI-driven soil intelligence platform

    Elaniti develops AI and DNA-based soil intelligence tools that decode microbial activity, helping agribusinesses improve yields, reduce synthetic inputs and build healthier, more resilient soils.

PINC
    • Life Sciences
    • Agriculture
  • 1(12 months)
  • pauliggroup.com/this-is-pinc
  • Update Information

More venture news

  • Dogtooth Technologies secures £14m in funding from VCs to scale autonomous robotic crop harvesting
    Dogtooth Technologies
    8 Jul 2026

    Dogtooth Technologies secures £14m in funding from VCs to scale autonomous robotic crop harvesting

    EquityAgriculture
  • TaiSan raises £4.7m in funding led by Eos Advisory and Mercia Ventures for solid-state sodium-ion batteries
    TaiSan
    6 Jul 2026

    TaiSan raises £4.7m in funding led by Eos Advisory and Mercia Ventures for solid-state sodium-ion batteries

    EquityDeep Tech
  • Revolver Therapeutics raises £600k in funding led by QantX to develop peptides that shut down cancer-driving proteins
    Revolver Therapeutics
    6 Jul 2026

    Revolver Therapeutics raises £600k in funding led by QantX to develop peptides that shut down cancer-driving proteins

    EquityLife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn